Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218491 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 111
- Enrollment target
NCT00218491 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 111 participants.
The verdict
NCT00218491, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 111 participants
- Enrollment target
Study Summary
Currently, no effective drug treatment exists for cocaine dependence. Glutamate levels are disrupted with long-term cocaine use. N-acetyl cysteine (NAC) is a drug that is metabolized by the body to form cysteine, an active compound that normalizes glutamate levels. The purpose of this study is to determine the safety and effectiveness of NAC in treating cocaine dependent individuals.
Interventions
- DRUG N-Acetylcysteine
- DRUG Matching Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2005-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218491
The ClinicalTrials.gov registry entry for NCT00218491 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which N-Acetylcysteine is the first listed.
NCT00218491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218491 about?
NCT00218491 is a clinical study titled "Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1". Currently, no effective drug treatment exists for cocaine dependence. Glutamate levels are disrupted with long-term cocaine use. N-acetyl cysteine (NAC) is a drug that is metabolized by the body to form cysteine, an active compound that normalizes glutamate levels. The purpose of this study is to de...
What is the current status of trial NCT00218491?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 111 participants. The study started on 2005-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00218491?
The interventions under investigation include: N-Acetylcysteine (DRUG), Matching Placebo (DRUG).
Who is sponsoring clinical trial NCT00218491?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.